Main > ONCOLOGY (**) > Breast Cancer *** > Treatment * > Co: USA. E. Gemcitabine.HCl Inj.+

---

Co: USA. E. Gemcitabine.HCl Inj.+'s subsections
(*) USA Initial Approval Year: 1996
+Paclitaxel
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>USA Expiration: 2010. 05.15
TradeMark
TradeMark Web-Site

Co: USA. E. Gemcitabine.HCl Inj.+'s products
This section has no products